Antimicrobial Textile Dyeing and Finishing Patents: Leaders & Trends 2026
- 132 of 168 families sit in D06M (textile chemical treatment) with A01N biocide claims layered on top in 73 families — most filings combine a chemistry class with a textile-application class rather than staking out either alone.
- Filing has kept accelerating past its 2018 peak of 12 the 2022 midpoint of 3 filings looks like a trough, not a ceiling, before activity picked back up toward the most recent count of 4 (still partial).
- India and the United States each lead with 27 filings ahead of the EPO's 21, Japan's 16 and Australia's 11 — filing strategy here is genuinely multi-jurisdictional rather than anchored to one office.
What this landscape covers
Antimicrobial textile dyeing and finishing sits at the junction of chemical treatment and biocide chemistry: a fabric substrate is dyed or finished with an agent designed to resist bacterial growth through repeated wash cycles. The 168 patent families in this dataset span filings from 2017 through a partial 2026, and the technology composition shows why the field resists a single classification — D06M textile chemical treatment claims dominate at 132 families, but the majority pair with A01N biocide and agrochemical claims, and smaller but consistent overlaps with A61K medicinal preparations and C09D coatings show the same finishing chemistry being claimed for skincare, cleaning and coating uses.
Filing activity peaked early, at 12 families in 2018, dipped through the mid-2020s, and has been climbing again — evidence of a technology that cooled after an initial wave of broad claims and is now being re-approached with narrower, more defensible filings. Publication lag means the last one to two years understate true filing volume.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology mix
Two views of the same 168 families: how filing volume has moved year over year, and which classification codes the claims actually sit in.
Filing trend, 2017-2026
From 11 filings in 2017 to a peak of 12 in 2018, down to a 2022 midpoint of 3, and rising again toward the most recent count of 4 — a partial year that will revise upward as publications catch up.
IPC subclass composition
D06M (textile chemical treatment) anchors the field at 132 families; A01N (biocides) at 73 is the next-heaviest overlap, followed by C07C, A61K, C11D, A61Q, C09D and A41D — each representing a different downstream use of the same finishing chemistry.
Shares are the percentage of the 168 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Antimicrobial Textile Dyeing and Finishing with Eureka
This page is one run against one query. Ask Eureka your own question about antimicrobial textile dyeing and finishing and every answer comes back with the patent numbers behind it.
Try EurekaThe records other filings build on
EP3543396B1 — Organic Antimicrobial Textile (Livinguard AG)
Filed by Livinguard AG and granted with an effective date of 2021-12-15, this record is representative of the field's current claim style: an organic antimicrobial treatment applied directly to textile substrates rather than relying on metallic or nanoparticle agents.Title and abstract are machine-translated from the original German filing.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US4160833A | 1,2,4-Benzotriazine-1,4-di-N-oxide derivatives | 74 |
| 2 | US20030056297A1 | Multifunctional textiles | 48 |
| 3 | EP3061864A1 | Textiles having antimicrobial properties | 35 |
| 4 | US20100120311A1 | Method for providing textiles with desensitized silver components | 32 |
| 5 | EP1053989A2 | Hydroxydiphenyl ether compounds | 31 |
| 6 | US20020014178A1 | Biocide compositions and methods and systems employing same | 26 |
| 7 | US3817702A | Antimicrobial textile materials | 25 |
| 8 | US4339462A | Antimicrobial 3-hydroxydiphenyl ethers | 23 |
| 9 | US6376522B1 | 4-hydroxyisothiazole compounds | 21 |
| 10 | WO2016135344A1 | Textiles having antimicrobial properties | 19 |
Citation counts reward older filings that have had more years to accumulate references — read them as markers of foundational influence, not of current commercial weight.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing strategy
Three patterns stand out once the counts are read against each other rather than in isolation.
Chemistry and application claims are filed together
Most families in this dataset don't claim a biocide or a textile treatment in isolation — they claim the combination. A filing that only covers the chemical agent, without the textile application, is competing in a much thinner slice of the art.
The field cooled and is now re-accelerating
An early wave of broad claims around 2018 gave way to a multi-year slowdown. The renewed climb toward 2026 suggests narrower, more defensible filings are now being made around specific chemistries rather than broad antimicrobial-finish claims.
No single office dominates prosecution
India and the United States sit level at the top, with the EPO, Japan and Australia each taking a meaningful share. A filer clearing this space needs freedom-to-operate checks across at least three offices, not one.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to antimicrobial textile dyeing and finishing, with the prior art for and against each one.
Who holds the ground, and where it's thin
Citation leaders and recent-year momentum tell different stories: the most-cited records are a decade or more old, while several named assignees show zero filings in the latest year — a sign of either dormancy or a strategy that has already moved past this specific claim style.
US4160833A anchors the biocide side
The benzotriazine-di-N-oxide compound behind the field's most-cited record predates the current wave of textile-specific filings by decades, showing how much of today's antimicrobial finishing chemistry traces back to earlier agrochemical and biocide work.
Several named holders show no recent activity
Assignees including Green Impact Holdings, Sanitized AG, Ciba Specialty Chemicals Holding, Ciba Geigy, Procter & Gamble and Nordic Biotechnology Group all show zero filings in the latest tracked year, one with a full -100% year-on-year drop.
Bayer and Henkel share the field's densest collaboration link
The strongest co-assignee pairing in this dataset, at two shared families, is between Bayer and Henkel — a modest but notable signal given how few multi-assignee families exist here at all.
| Assignee | Recent year | YoY |
|---|---|---|
| Green Impact Holdings | 0 | — |
| Sanitized AG | 0 | — |
| Ciba Specialty Chemicals Holding Inc. | 0 | — |
| Ciba Geigy AG | 0 | — |
| Procter & Gamble Company | 0 | — |
| Nordic Biotechnology Group Ltd. | 0 | -100% |
| CIBA GEIGY CORP | 0 | — |
| Ciba Specialty Chemicals AG | 0 | — |
Where to take this
The counts here answer what has been filed. Deciding what to file next means running the specific chemistry or application against this same corpus.
Check freedom-to-operate on a specific agent class
Run the actual biocide or finishing chemistry under consideration against the D06M/A01N overlap to see which combinations are already claimed and which are still open.
Run a claim search in Patsnap EurekaTrack dormant assignees before they re-file
Several holders with zero recent filings still control foundational citations — worth monitoring for renewed activity or licensing moves.
Set up assignee monitoring in Patsnap EurekaCommon questions on this landscape
The dataset shows citation leadership concentrated in a handful of legacy chemistry holders, with US4160833A's benzotriazine compound the single most-cited record at 74 citations. Recent filing momentum is more diffuse: several previously active assignees, including Green Impact Holdings, Sanitized AG and Procter & Gamble, show no filings in the latest tracked year. This split between historic citation weight and current filing activity means the field's technical foundations and its active competitive front are not held by the same players.
The core classification is D06M, textile chemical treatment, which covers 132 of the 168 families in this dataset. A01N, biocides and agrochemicals, is the next heaviest at 73 families and typically overlaps with D06M rather than standing alone. Smaller but consistent overlaps appear in A61K (medicinal preparations), C11D (detergents), A61Q (cosmetics), C09D (coatings) and A41D (garments), reflecting how the same finishing chemistry gets claimed for different end uses.
Filing peaked early at 12 families in 2018, dropped to a midpoint of 3 by 2022, and has been climbing again since, reaching 4 filings in the most recent, still-partial year. Because publication typically lags filing by around 18 months, the true 2025-2026 filing count is understated in this data and likely higher once later publications land. The pattern reads as a cooling-then-reacceleration rather than a steady decline.
EP3543396B1, filed by Livinguard AG with an effective date of 2021-12-15, claims an organic antimicrobial textile treatment — notable for relying on organic chemistry rather than metallic or nanoparticle-based antimicrobial agents, which is a common alternative approach in this field. It represents current claim style in the space rather than a single dominant blocking patent; anyone assessing freedom to operate should check it specifically against organic-agent finishing routes rather than treating it as covering the whole antimicrobial textile category.
The IPC overlaps that appear at lower volume — A61Q (cosmetics-adjacent finishing), C09D (coating-layer adhesion) and C11D (detergent-compatible durability) — show thinner claim density than the core D06M/A01N combination. Enzyme-based antimicrobial finishes and garment-integrated barrier layers also sit outside the dominant biocide-chemistry cluster. These branches are worth a targeted prior-art search before filing, since they are under-represented relative to the field's overall volume rather than technically exhausted.
Research Antimicrobial Textile Dyeing and Finishing in depth with Eureka
Go past this page: query the whole antimicrobial textile dyeing and finishing corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.